Dolling, D
346  results:
Search for persons X
?
1

HER3 Is an Actionable Target in Advanced Prostate Cancer:

Gil, V ; Miranda, S ; Riisnaes, R...
Cancer research, 2021, 81 (24), pp. 6207 - 6218.  , 2022
 
?
2

CD38 in Advanced Prostate Cancers:

Guo, C ; Crespo, M ; Gurel, B...
https://discovery.ucl.ac.uk/id/eprint/10128740/1/1-s2.0-S0302283821000221-main.pdf.  , 2021
 
?
 
?
9

Genomics of lethal prostate cancer at diagnosis and castrat..:

Mateo, J ; Seed, G ; Bertan, C...
The Journal of clinical investigation, 2020, 130 (4), pp. 1743 - 1751.  , 2020
 
?
10

Early Post-treatment Prostate-specific Antigen at 4 Weeks a..:

Rescigno, P ; Dolling, D ; Conteduca, V...
European urology oncology, 2020, 3 (2), pp. 176 - 182.  , 2020
 
?
11

Targeting Bromodomain and Extra-Terminal (BET) Family Prote..:

Welti, J ; Sharp, A ; Yuan, W...
Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 24 (13), pp. 3149 - 3162.  , 2020
 
?
13

Adjuvant chemotherapy in upper tract urothelial carcinoma (..:

Birtle, A ; Johnson, M ; Chester, J...
https://eprints.whiterose.ac.uk/158311/1/Adjuvant%20chemotherapy%20in%20upper%20tract%20urothelial%20carcinoma%20%28the%20POUT%20trial%29-%20a%20phase%203,%20open-label,%20randomised%20controll.pdf.  , 2020
 
?
15

Androgen receptor splice variant-7 expression emerges with ..:

Sharp, A ; Coleman, I ; Yuan, W...
The Journal of clinical investigation, 2019, 129 (1), pp. 192 - 208.  , 2019
 
1-15